ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2,3,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2,4,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2,5,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3,3,Post inflammatory pigmentation change,Pigmentation changes NEC,Pigmentation disorders,Skin,N
3,4,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3,6,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
5,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
5,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5,5,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
6,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
6,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
7,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7,2,Skin test positive,Immunology skin tests NEC,Immunology and allergy investigations,Inv,N
8,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
9,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
9,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
9,4,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
10,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
10,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11,1,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
12,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
13,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
13,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
14,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
14,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
14,3,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
14,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
14,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
15,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
15,2,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
16,1,Subacute cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
16,2,Transient acantholytic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
17,1,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
18,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
19,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
19,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
19,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
19,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
19,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
19,6,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
19,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
19,8,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
20,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
21,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
21,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
21,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
21,4,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
22,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
22,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
23,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
23,2,Transient global amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
24,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
24,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
24,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
24,4,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
24,5,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
25,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
25,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
25,3,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
26,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
27,1,Post inflammatory pigmentation change,Pigmentation changes NEC,Pigmentation disorders,Skin,N
28,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
28,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
28,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
28,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
29,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
29,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
30,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
30,2,Pharyngeal oedema,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
30,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
31,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
32,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
32,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
32,3,Lacrimation decreased,Lacrimation disorders,Eye disorders NEC,Eye,N
33,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
33,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
33,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
33,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
33,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
